Stagezero Life Sciences Stock Analysis
| SZLS Stock | CAD 0.04 0.00 0.00% |
StageZero Life Sciences is overvalued with Real Value of 0.0336 and Hype Value of 0.04. The main objective of StageZero Life stock analysis is to determine its intrinsic value, which is an estimate of what StageZero Life Sciences is worth, separate from its market price. There are two main types of StageZero Life's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect StageZero Life's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of StageZero Life's stock to identify patterns and trends that may indicate its future price movements.
The StageZero Life stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. StageZero Life is usually not traded on Canada Day, Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. StageZero Stock trading window is adjusted to America/Toronto timezone.
StageZero |
StageZero Stock Analysis Notes
About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.16. StageZero Life Sciences last dividend was issued on the 18th of September 2020. The entity had 1:8 split on the 18th of September 2020. StageZero Life Sciences Ltd. focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. StageZero Life Sciences Ltd. was founded in 1998 and is headquartered in Richmond Hill, Canada. STAGEZERO LIFE operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 15 people. To find out more about StageZero Life Sciences contact James HowardTripp at 905 209 2030 or learn more at https://www.stagezerolifesciences.com.StageZero Life Sciences Investment Alerts
| StageZero Life generated a negative expected return over the last 90 days | |
| StageZero Life has some characteristics of a very speculative penny stock | |
| StageZero Life has high likelihood to experience some financial distress in the next 2 years | |
| StageZero Life Sciences has accumulated 1.8 M in total debt. StageZero Life Sciences has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist StageZero Life until it has trouble settling it off, either with new capital or with free cash flow. So, StageZero Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StageZero Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StageZero to invest in growth at high rates of return. When we think about StageZero Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 2.88 M. Net Loss for the year was (12.53 M) with profit before overhead, payroll, taxes, and interest of 1.18 M. | |
| StageZero Life Sciences has accumulated about 754.87 K in cash with (809.15 K) of positive cash flow from operations. | |
| Roughly 20.0% of the company outstanding shares are owned by corporate insiders |
StageZero Largest EPS Surprises
Earnings surprises can significantly impact StageZero Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2007-11-08 | 2007-09-30 | -2.88 | -2.4 | 0.48 | 16 | ||
2006-08-17 | 2006-06-30 | -1.44 | -1.92 | -0.48 | 33 | ||
2007-03-30 | 2006-12-31 | -1.44 | -2.4 | -0.96 | 66 |
StageZero Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.94 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate StageZero Life's market, we take the total number of its shares issued and multiply it by StageZero Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.StageZero Profitablity
StageZero Life's profitability indicators refer to fundamental financial ratios that showcase StageZero Life's ability to generate income relative to its revenue or operating costs. If, let's say, StageZero Life is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, StageZero Life's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of StageZero Life's profitability requires more research than a typical breakdown of StageZero Life's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (18.74) | (17.80) | |
| Return On Capital Employed | 1.10 | 1.16 | |
| Return On Assets | (18.74) | (17.80) | |
| Return On Equity | 1.37 | 1.44 |
Management Efficiency
StageZero Life Sciences has return on total asset (ROA) of (0.638) % which means that it has lost $0.638 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6885) %, meaning that it generated substantial loss on money invested by shareholders. StageZero Life's management efficiency ratios could be used to measure how well StageZero Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, StageZero Life's Return On Capital Employed is very stable compared to the past year. As of the 2nd of December 2024, Return On Equity is likely to grow to 1.44, though Return On Tangible Assets are likely to grow to (17.80). At this time, StageZero Life's Net Current Asset Value is very stable compared to the past year. As of the 2nd of December 2024, Tangible Asset Value is likely to grow to about 3.2 M, while Total Assets are likely to drop about 599.1 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.09) | (0.08) | |
| Net Current Asset Value | 40 K | 73.1 K | |
| Tangible Asset Value | 3.1 M | 3.2 M | |
| Tangible Book Value Per Share | (0.09) | (0.08) | |
| Enterprise Value Over EBITDA | (0.69) | (0.66) | |
| Price Book Value Ratio | (0.68) | (0.64) | |
| Enterprise Value Multiple | (0.69) | (0.66) | |
| Price Fair Value | (0.68) | (0.64) | |
| Enterprise Value | 5.6 M | 5.8 M |
Leadership effectiveness at StageZero Life Sciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (0.57) | Beta 0.074 | Return On Assets (0.64) | Return On Equity (1.69) |
Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of StageZero Life Sciences, as well as the relationship between them.StageZero Life Sciences Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. StageZero Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for StageZero Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
StageZero Life Outstanding Bonds
StageZero Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. StageZero Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most StageZero bonds can be classified according to their maturity, which is the date when StageZero Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
About StageZero Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how StageZero Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling StageZero shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as StageZero Life. By using and applying StageZero Stock analysis, traders can create a robust methodology for identifying StageZero entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (2.71) | (2.84) | |
| Operating Profit Margin | (1.84) | (1.93) | |
| Net Loss | (2.71) | (2.84) | |
| Gross Profit Margin | (0.11) | (0.12) |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding StageZero Life to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Other Information on Investing in StageZero Stock
StageZero Life financial ratios help investors to determine whether StageZero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in StageZero with respect to the benefits of owning StageZero Life security.